What is PocDoc?
PocDoc operates as a sophisticated digital health platform designed to democratize access to diagnostic testing. By enabling users to perform quantitative blood tests via a simple fingerprick and receive immediate, context-aware health assessments, the company addresses critical gaps in preventative care for conditions such as cardiovascular disease and diabetes. Beyond its core diagnostic capabilities, the platform has demonstrated remarkable versatility, having successfully digitized lateral flow testing during the global pandemic in partnership with NHS Digital and the Department of Health. Furthermore, its humanitarian impact is evidenced by collaborations with organizations like PATH to support polio eradication efforts, proving the platform's efficacy in remote and resource-constrained environments.
How much funding has PocDoc raised?
PocDoc has raised a total of $6.2M across 1 funding round:
Other Financing Round
$6.2M
Other Financing Round (2024): $6.2M with participation from Simplyhealth Group, Molten, and MMC Ventures
Key Investors in PocDoc
Simplyhealth Group
A long-standing UK-based health provider with over 140 years of experience, focusing on everyday health cash plans and innovative health services.
Molten
A prominent venture capital firm specializing in high-growth technology companies with global ambitions, providing strategic support for scaling operations.
MMC Ventures
A venture capital firm that backs and scales transformative technology companies, offering deep expertise in business model development and market disruption.
What's next for PocDoc?
With this latest infusion of capital, PocDoc is well-positioned to accelerate its enterprise-level growth strategy. The company is expected to focus on expanding its proprietary diagnostic test portfolio and deepening its integration with existing healthcare pathways. As the digital health landscape shifts toward decentralized, patient-centric care, PocDoc's ability to bridge the gap between rapid testing and actionable clinical insights will be a key driver of its long-term valuation. Future milestones will likely include scaling its corporate health offerings and further internationalizing its diagnostic infrastructure to meet the rising demand for accessible, data-driven preventative health solutions.
See full PocDoc company page
